ThermoGenesis Corp. (NASDAQ:KOOL)
The Company is a supplier of products that process, store and administer therapeutic doses of adult stem cells for treatment of disease and injury.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Profitability is just around the corner, and 2 years worth of cash on hand just in case.
Recs
This stock has been a loser but is starting to get good press. Should see a bump up over next few months if it doesn't prove itself down it will go.
Recs
This stock is on the verge of showing a profit. The growth in sales is app. 34% from the same quarter of a yeaar ago. Prediction is current quarter will be 2 cets on the plus side.They have increased their distribution and now have distribution in the Asian part of the world. The growth potential is outstanding.
Recs
Has alway had great technology and intellectual property. Finally, after twelve years of unfulfilled promises, KOOL now has a first-class management team which is delivering. KOOL is finally profitable and growing revenue and profit margins. Just announced a major deal to enter China and Hong Kong markets.
Recs
A moderately conservative way to play the risky stem cell sector. Projected for positve EPS in next year and would be low PE if hits estimate.
Recs
Good company with products having greater and greater demand.
Recs
MACD and price channels both show bearish levels for years to come.
Recs
With the stock trading near its 52-week low and some solid products and a GE partnership coming down the pipeline, I think the future is bright for this stock. Super value.
Recs
This could be huge.
Recs
Good technologies worth a lot if management can get its act together.
Recs
@ 2.50 I can do math easily and fantasize all day, lets see if we can get a rally first.
Recs
Has great demand and is one of the only stem cell stocks that will make a profit within the next year.
Recs
This company will be profitable very soon, and I don't see why this stock won't jump within a year or two.
Recs
it is partnered with GE and other big wigs. It dropped on not meeting their demand
Recs
industry leader with unique products for which demand will increase
Recs
No matter who wins the "stem cell supply war" this company manufactures the device in which they will be stored. Income generated from both the machines and the residules (bags, cleaning supplies, maintenance contracts) makes each sale worth many $$$. Should perform better than most pix made by the fool.
Recs
stem cells are kool.
Recs
FDA approval for cyroseal 1st Q07
Recs
More of a risk - but this is CAPS!
Recs
Stem cell cryogenic storage. Gov't just released first 12 million out of 79 million to this and a few other companies. In partnership with GE, definite buyout target. Bigger upside if Dems take congress.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 22 : 1 2 Next »